Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected

Psychopharmacology

Volumn 189, Issue 4, 2007, Pages 557-563

  Kuypers, Kim P C ^a,b   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Acute; MDMA; Memory; Methylphenidate; Spatial; Task complexity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTOXICATION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; SPATIAL MEMORY; TASK PERFORMANCE;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HALLUCINOGENS; HUMANS; LINEAR MODELS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REACTION TIME; SPACE PERCEPTION;

EID: 33751240096     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0321-7     Document Type: Article

References (28)

1. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51:1532-1537
2. Broening HW, Morford LL, Inman Wood SL, Fukumura M, Vorhees CV (2001) 3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21:3228-3235
3. Cole JC, Sumnall HR (2003) Altered states: the clinical effects of ecstasy. Pharmacol Ther 98:35-58
4. Dafters RI, Hoshi R, Talbot AC (2004) Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users. Psychopharmacology 173:405-410
5. Dornhoefer SM, Unema PJ, Velichkovsky BM (2002) Blinks, blanks and saccades: how blind we really are for relevant visual events. Prog Brain Res 140:119-131
6. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196-206
7. Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology 162:203-214
8. Fox HC, Parrott AC, Turner JJ (2001) Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol (Oxf) 15:273-281
9. Gouzoulis Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719-725
10. Kuypers KP, Ramaekers JG (2005) Transient memory impairment after acute dose of 75 mg 3,4-methylene-dioxymethamphetamine. J Psychopharmacol (Oxf) 19:633-639
11. Luciana M, Collins PF, Depue RA (1998) Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex (NY, NY 1991) 8:218-226
12. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology 143:417-425
13. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 10:129-138
14. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:Rc65
15. Morford LL, Inman Wood SL, Gudelsky GA, Williams MT, Vorhees CV (2002) Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine. Eur J Neurosci 16:491-500
16. Morgan MJ (1998) Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252-264
17. Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Human Psychopharmacol 16:557-577
18. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J (2002) The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26:387-396
19. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A (2001) Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study. Vol. 16:619-625 URLJ: http://www.interscience.wiley.com/ jpages/0885-6222/
20. Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2004) Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav 29:743-752
21. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 175:63-69
22. Sprague JE, Preston AS, Leifheit M, Woodside B (2003) Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 79:281-287
23. Verdejo Garcia AJ, Lopez Torrecillas F, Aguilar de Arcos F, Perez Garcia M (2005) Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav 30:89-101
24. Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196-202
25. Vermeeren A, Jackson JL, Muntjewerff ND, Quint PJ, Harrison EM, O'Hanlon JF (1995) Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests. Psychopharmacology 118:1-9
26. Wareing M, Fisk JE, Murphy P, Montgomery C (2005) Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Hum Psychopharmacol 20:115-123
27. Wareing M, Fisk JE, Murphy PN (2000) Working memory deficits in current and previous users of MDMA ('ecstasy'). Br J Psychol 91:181-188
28. Wareing M, Murphy PN, Fisk JE (2004) Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology 173:391-397